These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2005-000459-14 A Stratified Phase II Study of Cetuximab (ErbituxTM) for the Treatment of Recurrent Glioblastoma Multiforme / Estudio de fase II estratificado de cetuximab para el tratamiento del glioblastoma multifo... not-yet-due
Not reported 2006-001765-42 A prospective and randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with new-onset diabetes mellitus after renal transplantation (REVERSE study... 2015-04-17 due-trials
Completed, report not yet due 2008-000756-27 Activity of sunitinib in esophageal cancer, melanoma and sarcoma. 2024-11-13 not-yet-due
Reported results 2009-009429-26 A PILOT STUDY TO EVALUATE THE EFFECT OF TRIGGERING FINAL OOCYTE MATURATION WITH GnRHa OR hCG ON ENDOMETRIAL RECEPTIVITY PARAMETERS AND THE LUTEAL PHASE IN OOCYTE DONORS 2012-01-13 due-trials
Not reported 2009-011817-26 A pilot study to assess the feasibility of unrelated umbilical cord blood transplantation with coinfusion of third-party mesenchymal stem cells after myeloablative or nonmyeloablative conditioning in ... 2018-11-09 due-trials
Ongoing 2009-012089-30 Frequency and mechanisms of resistance to IGF-1 generation in non-GH deficient short children with low IGF-1 concentration not-yet-due
Ongoing 2010-018491-24 Effect of aminobisphosphonates and statins on circulating Vy9Vd2-T cells not-yet-due
Completed, but no date, and reported results 2010-023058-35 A Two-Stage Phase II Study of Autologous TriMix-DC Therapeutic Vaccine in Combination with Ipilimumab in Patients with Previously Treated Unresectable Stage III or IV Melanoma bad-data
Other 2010-023777-19 Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants: the SToP-BPD study not-yet-due
Completed, but no date 2011-000900-16 AA randomized phase II clinical trial on the efficacy of axitinib as a monotherapy or in combination with lomustine for the treatment of patients with recurrent glioblastoma bad-data
Completed, report not yet due 2011-001410-33 Randomized phase II clinical trial on mRNA electroporated autologous dendritic cells for stage III/IV melanoma in patients who are free from measurable tumor lesions following the local treatment of m... 2024-11-13 not-yet-due
Completed, but no date, and reported results 2011-003321-99 Comparison of Volulyte® versus Tetraspan® in patients undergoing cardiopulmonary bypass. bad-data
Completed, report not yet due 2011-005457-31 The effect of the combination of midazolam with Ropivacaine in loco-regional anesthesia. Het effect van de combinatie van Ropivacaïne met Midazolam bij loco-regionale anesthesie. 2024-08-06 not-yet-due
Completed, report not yet due 2011-005534-19 The effect of peri-operative anti-inflammatory treatment on postoperative muscle weakness and muscle fatigue in elderly elective surgery patients: a double blinded randomized placebo-controlled trial.... 2024-12-02 not-yet-due
Reported results 2012-000584-25 Propofol and etomidate. Are they also safe for patients with Brugada-Syndrome? 2018-03-31 due-trials
Listed as ongoing, but also has a completion date 2012-005226-29 Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease 2017-09-01 bad-data
Completed, but no date, and reported results 2013-000583-29 Corifollitropin alfa followed by hp-HMG versus recombinant FSH in young poor ovarian responders. A multicentre randomized controlled clinical trial bad-data
Completed, report not yet due 2013-000665-36 A phase II, open label study of everolimus with fulvestrant in postmenopausal women with hormone receptor-positive HER-2 negative AI and fulvestrant treated, locally advanced or metastatic breast canc... 2024-11-13 not-yet-due
Completed, report not yet due 2013-000795-15 An open-label pilot clinical trial of MAGE-A3 and MAGE-C1 mRNA electroporated autologous dendritic cell vaccination in combination with lenalidomide maintenance therapy for multiple myeloma after firs... 2024-09-17 not-yet-due
Ongoing 2013-002373-22 ThE SoF-Trial (SoFT) - The Effect of Sevelamer on FGF23 Trial - A clinical trial assessing the quantitative effect of phosphate binding therapy on FGF23. not-yet-due
Reported results 2013-002815-88 Randomised comparative trial of Bupivacaine and 2-Chloroprocaine by caesarean section. Vergelijkende gerandomiseerde studie van BupivacaÏne en 2- ChloroprocaÏne bij keizersnede. 2013-12-31 due-trials
Completed, report not yet due 2013-004206-26 The effect of methylphenidate (Ritalin ®) on the severity of stuttering. 2024-07-22 not-yet-due
Completed, report not yet due 2013-004232-29 A phase II proof of concept study to evalute the efficacy and safety of deep subcutaneous lanreotide Autogel 120 mg / 28 days on symptoms and healing of the esophageal and gastric mucosa in patients w... 2024-08-05 not-yet-due
Completed, report not yet due 2013-004908-20 Cerebral effect of paracetamol measured by f-MRI 2024-08-06 not-yet-due
Completed, report not yet due 2013-004966-33 A phase II clinical trial on the combination of dabrafenib and trametinib for BRAF-inhibitor pretreated patients with advanced BRAF V600 mutant melanoma 2024-11-13 not-yet-due
Ongoing 2013-005475-41 Sulfamethoxazole treatment of primary PREPL deficiency Sulfamethoxazole ter behandeling van primaire PREPL deficiëntie not-yet-due
Ongoing 2013-005528-40 Long-term, prospective study evaluating clinical and molecular biomarkers of epileptogenesis in a genetic model of epilepsy – Tuberous Sclerosis Complex. Een lange-termijn, prospectieve studie om k... not-yet-due
Completed, but no date 2014-000308-82 Lanthanum Carbonate (Fosrenol®) to reduce oxalate excretion in patients with secondary hyperoxaluria and nephrolithiasis: a short-term, prospective, open-label, efficacy and safety clinical trial bad-data
Completed, report not yet due 2014-000678-20 Does isocapnic hyperventilation hasten early recovery with sevoflurane and desflurane in O2/air? 2024-08-06 not-yet-due
Not reported 2014-001835-35 Transdermal testosterone gel for poor ovarian responders. A multicenter double-blind placebo controlled randomized trial. 2023-07-11 due-trials
Completed, report not yet due 2014-004713-91 Epidural ropivacaine as part of a multimodal postoperative pain treatment following thoracolumbar spinal fusion surgery. 2024-08-06 not-yet-due
Completed, report not yet due 2015-000537-69 Real time monitoring of blood propofol concentration 2024-08-06 not-yet-due
Ongoing 2015-000689-79 Rectal preserving treatment for early rectal cancer. A multi-centred randomised trial of radical surgery versus adjuvant chemoradiotherapy after local excision for early rectal cancers. not-yet-due
Other 2015-002328-24 Evaluation of 68GaNOTA-Anti-HER2 VHH1 uptake in brain metastasis of cancer patients not-yet-due
Completed, report not yet due 2015-002645-54 Comparison of efficacy between dexmedetomidine (DEX) and nicardipine (NIC) in adult facial surgery 2024-08-06 not-yet-due
Completed, but no date, and reported results 2015-002744-14 Comparative study with prilocaine 1% and prilocaine 1.5% for ultrasound guided axillary brachial plexus blockade bad-data
Not reported 2015-004251-47 Validation of central venous (Port A Cath®) blood draws for ciprofloxacin pharmacokinetic research in patients under treatment for childhood cancer. Validatie van bloedafnames via een Port A Cath® ... 2020-06-10 due-trials
Completed, report not yet due 2015-005146-55 The effect of methylphenidate (Ritalin®) on the severity of stuttering. 2024-07-22 not-yet-due
Ongoing 2015-005154-35 N-acetylcysteine for the treatment of cannabis dependence: working mechanisms not-yet-due
Completed, report not yet due 2016-000228-24 Eradication of H. pylori infection in Belgium: bismuth versus first line therapy 2024-08-05 not-yet-due
Reported results 2016-000813-63 Comparative doubleblind study with prilocaine 2 % and 2-chloroprocaine for elective caesarean section. 2016-12-31 due-trials
Ongoing 2016-002164-13 Quantification of 68GaNOTA-Anti-HER2 VHH1 Uptake in metastasis of Breast carcinoma and cancer patients and Assessment of Repeatability – Pilot study not-yet-due
Completed, report not yet due 2016-002323-28 Blood concentration and pharmacokinetic analysis of propofol following administration of single induction dose in small children 2024-08-06 not-yet-due
Completed, report not yet due 2016-003198-17 A Prospective Interventional Pilot Study on the Use of Valproic Acid for Treatment of Idiopathic Nephrotic Syndrome 2024-07-19 not-yet-due
No trial status on register 2016-003673-18 Can we with vitamin D3, improve the innate immune system? Kunnen we door middel van een behandeling met vitamine D3, het aangeboren immuunsysteem verbeteren? Peut-on au moyen d'un traitement ave... bad-data
Reported results 2017-000200-23 Phase II clinical trial on the combination of avelumab and axitinib for the treatment of patients with recurrent glioblastoma 2020-09-16 due-trials
Completed, report not yet due 2017-001253-13 Does cerebral hypoperfusion play a role in reduced axonal metabolism and clinical disability in patients with multiple sclerosis ? Speelt cerebrale hypoperfusie een rol in het verminderd axonaal me... 2024-09-30 not-yet-due
Exempt 2017-001471-23 Phase I/IIa study to evaluate the safety, biodistribution, radiation dosimetry and tumor imaging potential of 68GaNOTA-Anti-MMR-VHH2, a new radiopharmaceutical for in vivo imaging of Tumour-Associated... not-yet-due
Ongoing 2017-001556-67 The effect of emollients on pruritus in psoriasis not-yet-due
Ongoing 2017-002571-25 A comparison between corifollitropin alfa and recombinant FSH for follicular recruitment in women with polycystic ovaries who undergo IVM treatment not-yet-due
Other 2017-003280-35 AMENDMENT TITLE: Phase I clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+ / CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and AS01 in combination with intravenously... not-yet-due
Completed, report not yet due 2017-004038-28 Comparative Prospective Randomized Study in Postoperative Cardiac Surgery Patients on Analgesia with Morphine Continuous Infusion or Sublingual Sufentanil (Zalviso®). 2024-08-06 not-yet-due
Ongoing 2017-004429-34 Histological and Transcriptional Changes caused by Endometrial Flushing with Lipiodol: A Cross Over Study. not-yet-due
Completed, but no date 2017-005005-12 Initiation of ovarian stimulation with recombinant-human FSH (Bemfola®) in the late follicular phase, a randomised controlled study. bad-data
Completed, but no date 2018-000016-19 Randomized comparative double blind prospective study with hyperbaric prilocaine 2 % and 3 different doses of sufentanil for elective caesarean section. bad-data
Completed, report not yet due 2018-000045-40 The effects of nitrous oxide on human vision 2024-08-06 not-yet-due
Completed, report not yet due 2018-000105-23 Oral dydrogesterone (OD) versus micronized vaginal progesterone (MVP) for luteal phase support (LPS) in IVF/ICSI: pharmacokinetics and the impact on the endometrium, the microbiota of the genital trac... 2024-02-14 not-yet-due
Not reported 2018-000689-13 Clinical pregnancy rate for frozen embryo transfer with HRT: a pilot study comparing 1 versus 2 weeks of treatment 2023-05-15 due-trials
Other 2018-001751-12 Vitamin D Supplementation to increase free testosterone in Type 2 Diabetes Mellitus men: a Placebo-controlled Randomized Clinical Trial not-yet-due
Other 2018-002000-13 Effect of recombinant FSH dosing following corifollitropin alfa in patients undergoing IVF/ICSI in a GnRH antagonist protocol: a randomized controlled dose-finding study. not-yet-due
Ongoing 2018-003156-20 Natural cycle versus hormone replacement therapy cycle for a frozen-thawed embryo transfer in PGT patients: a randomised trial. not-yet-due
Completed, report not yet due 2018-004003-39 A stratified dual-arm open-label two-stage phase 2 trial of trametinib in patients with advanced pretreated BRAFV600 wild-type melanoma 2024-11-13 not-yet-due
Not reported 2019-000709-55 Sugammadex dose-finding study for reversal of deep rocuronium-induced neuromuscular block 2022-11-16 due-trials
Not reported 2019-000971-17 Double trigger and ovum retrieval vs. conventional antagonist ovarian stimulation protocol in poor prognosis women undergoing IVF/ICSI: A pilot study 2023-06-29 due-trials
Ongoing 2019-002094-55 Safety and feasibility of S-Caine patch use in children under the age of three Veiligheid en haalbaarheid van S-Caine patch gebruik bij kinderen onder de leeftijd van drie not-yet-due
Completed, report not yet due 2019-003668-32 A randomized phase II clinical trial of SBRT and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)+/ CD141 (BDCA-3)+ myeloid dendritic cells in NSCLC 2024-04-18 not-yet-due
Other 2019-004671-39 The effect of handheld-multimedia versus midazolam premedication on the level of perioperative anxiety in pediatric day-care. A randomized controlled trial. not-yet-due
Completed, reported early 2019-004750-28 Electrocardiographic And Clinical Effects Of Target-Controlled Infusion Of Propofol In Adults With Brugada Syndrome. A Pilot Study. 2024-09-16 not-yet-due
Ongoing 2020-002483-31 Phase II study to evaluate the clinical potential of 68GaNOTA-Anti-MMR-VHH2 for in vivo imaging of MMR-expressing Macrophages by means of Positron Emission Tomography (PET) in oncological lesions, car... not-yet-due
Reported results 2020-003682-19 Post-operative patient controlled intravenous oxyco-done vs patient controlled intrav nous piritramide. A randomized controlled trial. 2023-10-16 due-trials
Ongoing 2020-004491-17 Dydrogesterone versus micronized vaginal progesterone (MVP) for luteal phase support (LPS) in hormone replacement therapy (HRT) frozen embryo transfer (FET) cycles. not-yet-due
Completed, reported early 2020-004723-17 Clinical usefulness and influence on oesophageal motility of pyridostigmine for dysphagia in systemic sclerosis. Klinische meerwaarde van pyridostigmine bij patiënten met systeemsclerose die dysfa... 2024-05-06 not-yet-due
Ongoing 2020-005208-20 Depo-Trigger trial: GnRH agonist DEPOt TRIGGER for final oocyte maturation in breast cancer patients undergoing fertility preservation: a pilot study. not-yet-due
Ongoing 2020-005914-16 COmbining Interventions of fertility preservation to Mitigate fertility loss after BReAst cancer not-yet-due
Completed, report not yet due 2021-005426-18 Diuretic Treatment in Acute Heart Failure with Volume Overload Guided by Serial Spot Urine Sodium Assessment 2024-07-01 not-yet-due
Other 2021-005575-40 A phase II study to evaluate the imaging potential of 68GaNOTA-Anti-MMR VHH2 for in vivo imaging of MMR-expressing Macrophages by means of Positron Emission Tomography (PET) in patients with non-small... not-yet-due
Other 2022-001291-34 A phase-2 clinical trial of regorafenib in patients with pretreated advanced melanoma not-yet-due
Not reported 2022-002310-16 Endometrial gene expression profiles during ovarian stimulation with recombinant human FSH with or without the addition of recombinant human LH in genuine poor responders. 2023-07-10 due-trials
Other 2022-002836-30 Investigating fundamental mechanisms of mental and physical fatigue using neurotransmitter reuptake inhibitors and electroencephalography: a randomized counterbalanced crossover trial not-yet-due
Other 2022-003049-37 Luteal phase ovarian stimulation with Follitropin delta and dydrogesterone: a randomized cross over pilot trial not-yet-due
Other 2022-003925-23 Pain medication tapering for patients with Persistent Spinal Pain Syndrome Type II, treated with Spinal Cord Stimulation. not-yet-due